Warning letterPosted June 23, 2026
FDA warning letter to Great Enterprise - Group - Inc.
Foreign Supplier Verification Program (FSVP)
FDA posted a warning letter to Great Enterprise - Group - Inc. on June 23, 2026; the letter is dated April 17, 2026. Subject: Foreign Supplier Verification Program (FSVP). Issuing office: Office of Inspections and Investigations.
On the record
- Company
- Great Enterprise - Group - Inc.
- Subject
- Foreign Supplier Verification Program (FSVP)
- Issuing office
- Office of Inspections and Investigations
- Letter dated
- 2026-04-17
- Posted by FDA
- 2026-06-23
- Source
- FDA warning letters ↗
CFR cited
The record cites 1 section of 21 CFR Parts 1 and 113.
The full record
An account shows the violations FDA described and each CFR section it cited.
What a warning letter is
A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.
More
Watch Great Enterprise - Group - Inc
A free account shows the last 7 days of every FDA, SEC and ClinicalTrials.gov source. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA warning letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Great Enterprise - Group - Inc. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.